# Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions

> **NCT06569381** · PHASE1 · COMPLETED · sponsor: **Overseas Pharmaceuticals, Ltd.** · enrollment: 18 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **DRUG:** Pirfenidone Modified-Release Tablets
- **DRUG:** Pirfenidone Modified-Release Tablets

## Key facts

- **NCT ID:** NCT06569381
- **Lead sponsor:** Overseas Pharmaceuticals, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-18
- **Primary completion:** 2024-10-01
- **Final completion:** 2024-12-08
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06569381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06569381, "Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06569381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*